Dr. Melanie Weigert, of University of Chicago, is a 2021 recipient of OCRA’s Mentored Investigator Grant. With her project, “Genome-Wide Profiling of 5-hydroxymethylcytosine on Cell-Free DNA,” Dr. Weigert aims to identify biomarkers that can predict how cancer cells will respond to platinum-based treatments, helping guide patients with potentially platinum-resistant cancer toward alternative therapies. Dr. Weigert’s … Continued
This may be a short month, but it’s not short on all the many ways to get involved. In the meantime, we hope you feel the Valentine love from all of us at OCRA. Advocacy Patient Support & Programs Events Research Ways to Give
The ovarian cancer community is counting on a hero… and that OCRA Hero could be you! If you’re looking to do good in 2022, it can be as simple (and fun!) as turning your favorite activity into a fundraiser. You can increase awareness and support just by going cycling, getting crafty, giving a concert, gathering … Continued
Happy new year! While the temperatures may be chilly for many of us, we hope everyone is keeping warm with renewed hope for a year of progress toward our mission, and a strong sense of community. Only three weeks into 2022, and we already have a lot to share. So, without further ado … Research … Continued
OCRA is pleased to announce the recipients of two research prizes, selected by members of our Scientific Advisory Committee for their notable contributions to the field of ovarian cancer research and commitment to future discoveries. Dr. Kathleen Cho Awarded Rosalind Franklin Excellence in Ovarian Cancer Research Prize The Rosalind Franklin Excellence in Ovarian Cancer Research … Continued
It’s a new year, and there’s no better time to commit to simple actions that can make a big impact! So simple, that they take between one minute and half an hour to complete. Set OCRA as your AmazonSmile charity of choice. If you’re shopping with Amazon, this is a simple and effective, “set it and … Continued
New study findings not only reveal where the most common ovarian cancer subtype originates in certain patients, but also point to the future possibility of being able to predict who will get the disease. The research, published in Cell Reports, was led by Clive N. Svendsen, PhD, of Cedars-Sinai Medical Center and OCRA’s Scientific Advisory Committee … Continued
OCRA is pleased to announce the offering of an additional four groups to our Staying Connected online support group series. Staying Connected is facilitated by our Patient Support team and meets weekly or monthly, depending on the focus of the group. The meetings provide connection with others who share similar experiences and concerns facing ovarian … Continued
More breakthroughs are on the horizon, as OCRA has awarded grants to 22 dedicated scientists at 15 prestigious medical institutions to enable future ovarian cancer discoveries. With this funding, OCRA grantees aim to answer questions that have vexed the scientific community, building on our collective knowledge and identifying new opportunities for ovarian cancer prevention and … Continued
Dr. Anne van Harten, of the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award. With her project, “Targeted MDM2 Degradation as a Novel Treatment for Ovarian Cancer,” Dr. van Harten is designing and testing a new compound to target a … Continued
OCRA grantees Ignacio Vázquez-García, PhD and Sohrab Shah, PhD, of Memorial Sloan Kettering Cancer Center, along with colleagues, have found that distinct mutational processes determine the different mechanisms by which certain ovarian cancer tumors are able to evade the immune system and continue to grow. These learnings may lead the way to future immunotherapeutic approaches that can more … Continued
Dr. Sammy Ferri-Borgogno, of UT MD Anderson Cancer Center, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award. With her project, “Spatially-Resolved Cellular and Transcriptome Analyses of Ovarian Cancer,” Dr. Ferri-Borgogno is working to better understand ovarian cancer microenvironments, to find ways to better combat drug resistance. What initially sparked your … Continued
Get email updates about research news, action alerts, and ways to join the fight.
